ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
5
views
0
references
Top references
cited by
2
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,256
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
A PHASE 2B STUDY OF SELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Author(s):
N Kalakonda
,
F Cavallo
,
G. FOLLOWS
,
A Goy
,
J Vermaat
,
O Casasnovas
,
O Lavee
,
M Maerevoet
,
J. Zijlstra
,
S. Bakshi
,
R Bouabdallah
,
S. Choquet
,
R Gurion
,
B. HILL
,
U Jaeger
,
J. Sancho
,
M. SCHUSTER
,
C Thieblemont
,
F De la Cruz
,
M Egyed
,
S Mishra
,
F OFFNER
,
T Vassilakopoulos
,
K Warzocha
,
A. Oluyadi
,
D McCarthy
,
X Ma
,
K Corona
,
J. SHAH
,
E. Van Den Neste
,
M Canales
,
F. CAVALLO
,
A. GOY
,
J SANCHO
,
M Schuster
,
S. MISHRA
,
D. Mccarthy
Publication date:
2019
Journal:
Hematological Oncology
Read this article at
ScienceOpen
Publisher
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
International Journal of Management Studies
Author and article information
Journal
DOI::
10.1002/hon.31_2629
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
4,256
XpovioTM (selinexor) tablets [prescribing onformation]
Authors:
USPI Xpovio
Phase 1b study of selinexor, a first-in-class selective inhibitor of nuclear export (SINE) compound, in combination with doxorubicin in patients (pts) with locally advanced or metastatic soft tissue sarcoma (STS).
Authors:
Eoghan Malone
,
Jeremy Howard Lewin
,
Esmail Mutahar Al-Ezzi
…
Selinexor in combination with induction and consolidation therapy in older adults with aml is highly active
Authors:
Pardee
See all similar
Cited by
2
Selinexor: First Global Approval
Authors:
Yahiya Syed
The emerging roles of NGS in clinical oncology and personalized medicine
Authors:
Bashdar Hussen
,
Sara Abdullah
,
Abbas B.Q. Salihi
…
See all cited by